Summary This trial consists of obtaining and banking tissue samples of lung carcinoma, and when possible, portions of involved lymph nodes, as well as adjacent grossly uninvolved lung tissue during surgical resection. The tissue will provide a source of quality DNA, mRNA and protein for molecular analysis. Blood specimens will also be obtained to allow assessment of levels of circulating markers in lung cancer.